Vaccinex, Inc.
Pharmaceutical company · Rochester, New York, United States · OTC: VCNX
Vaccinex, Inc. is a pharmaceutical company headquartered in Rochester, New York, United States. Its shares trade on OTC under the ticker VCNX. It has received 12 US government small-business research awards (SBIR/STTR) from health agencies, $4.4 million in total, most recently in 2004. It has reported private securities offerings to the US SEC, most recently $200,155 sold in a notice filed in 2024.
Vaccinex at a glance
What does Vaccinex do?
US government research funding
12 SBIR/STTR small-business research awards from US health agencies, $4.4 million in total (1998 to 2004).
Private fundraising reported to the SEC
10 Form D notices; the most recent reported $200,155 sold (2024).
Frequently asked questions about Vaccinex
Where is Vaccinex headquartered?
Vaccinex, Inc. is headquartered in Rochester, New York, United States.
What does Vaccinex do?
Vaccinex, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Vaccinex a public company?
Yes. Vaccinex, Inc. trades on OTC under the ticker VCNX.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.